logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

China Biopharmaceuticals (01177): TQB3122 "PARP1 inhibitor" clinical trial application accepted by NMPA.

date
11/08/2025
Wisdom Financial APP News, China Biopharmaceutical (01177) announced that the new drug clinical trial application (IND) for the innovative drug TQB3122 "PARP1 inhibitor" developed independently by the group has been accepted by the China National Medical Products Administration (NMPA) and is intended to be used for the treatment of advanced malignant tumors.
Latest
3 m ago
U.S. stock anomaly | Eli Lilly (LLY.US) rises 3.8%, Wall Street major banks maintain its "buy" rating
8 m ago
U.S. President Trump: Considering holding another meeting with Nvidia on the Blackwell GPU. Previously requested the chip manufacturer to pay fees on part of the sales.
10 m ago
American President Trump: Will not reach a deal on the sale of Nvidia Blackwell graphics cards.
10 m ago
U.S. stock market anomaly | CEO says Q1 sales performance is unacceptable, C3.ai (AI.US) plunges over 23%
15 m ago
According to the news from the "Baotou Release" WeChat public account, on August 11, Baotou City held a government-business forum on the crystal silicon photovoltaic industry. Chen Zhichang, the Secretary of the Municipal Party Committee, Meng Qingwei, the Deputy Secretary of the Municipal Party Committee and Mayor, and 10 leaders of crystal silicon photovoltaic enterprises held face-to-face discussions to promote cooperation between government and enterprises and seek high-quality development of the crystal silicon photovoltaic industry. During the forum, leaders of companies such as Meike Shares, Daquan New Energy, Tongwei High-purity Crystal Silicon, Shuangliang Silicon Materials, Hongyuan New Materials, Newtex Silicon Materials, Jinko Solar, Xinyuan Silicon Materials, Atersun Solar Energy, and Dongfang Risheng New Energy each presented their views and suggestions regarding their own development and the industry situation, expressing confidence in the industry's prospects and in the development of Baotou, and indicating their commitment to deepen pragmatic cooperation with Baotou. Chen Zhichang stated that we must always maintain confidence in development, strengthen analysis and judgment of industry development trends, address industry cyclic adjustments correctly, further refine and improve policies and measures to support the development of the crystal silicon photovoltaic industry, and promote the high-quality development of the industry through collaborative efforts between government and enterprises. It is necessary to adhere to technological innovation to lead industrial innovation, focus on new technology R&D and downstream application expansion, deepen pragmatic cooperation with various enterprises, and promote the extension, complementation, and strengthening of the industrial chain. It is important to fully leverage the advantages of green electricity, increase the application of green production processes, play a leading and exemplary role in green and low-carbon development. Leveraging Baotou's solid equipment manufacturing industry foundation to expand cooperation with various enterprises and attract more industrial projects to Baotou. Increase stable and effective financial support for enterprises, promote in-depth government-bank-enterprise coordination, tailor financial solutions to address the financing difficulties faced by companies. Strengthen resource guarantee, make efforts to solve problems in areas such as water, electricity, land use, and industrial park facilities that are raised by companies, and continuously improve the business environment in practice.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.